Comparative effectiveness of Vortioxetine and Fluoxetine in patients with Depression - NI

Government Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

研究概览

暂无简介。

•1. Patients diagnosed with Single Episode Depressive Disorder or Recurrent Depressive
•Disorder (as per criteria in ICD-11)
•2. Drug naïve patients or patients not on treatment with anti-depressants for a duration of 4 weeks for Fluoxetine and 1 week for other anti-depressants
•3. Persons of any gender
•4. Age – 18 to 60 years
•5. Level of Education – 10th Pass
•6. Providing written informed consent

•1. Patients with psychiatric comorbidities like Bipolar Affective Disorder, Psychosis, Generalized Anxiety Disorder, OCD.
•2. Patients with comorbid substance dependence (except nicotine and caffeine)
•3. Patients with neurological disorders – Dementia, Parkinsonism, Tumors, Epilepsy and Organic brain damage
•4. Actively suicidal patients
•5. Patients who are pregnant or lactating
•6. Patients with Intellectual Disability
•7. Patients on anti-psychotics, anticholinergics and mood stabilizers
•8. Patients receiving Cognitive Behavioral Therapy, Cognitive Enhancement Therapy or any other psychological treatments in the last 6 weeks
•9. Patients who have received Electroconvulsive Therapy in last 3 months
•10. Patients having depression secondary to medical illness
•11. Patients with known history of hypersensitivity/ allergic reaction to Vortioxetine or Fluoxetine

发起方

Government Medical College and Hospital